Immunotherapy in glioblastoma treatment: Current state and future prospects

Area of Science:

• Neuro-oncology
• Immunology
• Cancer Research

Background:

• Glioblastoma is an aggressive brain tumor with poor prognosis despite standard treatments.
• Current therapies like surgery and chemoradiation offer limited survival benefits.
• Immunotherapy presents a promising avenue for glioblastoma treatment.

Purpose of the Study:

• To review the current status and progress of immunotherapy for glioblastoma.
• To provide an overview of fundamental immune targeting principles.
• To discuss promising immunotherapy strategies and future perspectives.

Main Methods:

• Literature review of current immunotherapy approaches for glioblastoma.
• Analysis of fundamental immune targeting concepts.
• Discussion of advanced strategies including CAR T-cell therapy, immune checkpoint inhibitors, cytokine-based treatments, oncolytic viruses, and vaccines.

Main Results:

• Immunotherapy offers novel treatment modalities for glioblastoma.
• Various strategies like CAR T-cell therapy and immune checkpoint inhibitors are under investigation.
• Challenges in glioblastoma immunotherapy require innovative solutions.

Conclusions:

• Immunotherapy holds significant potential for improving glioblastoma treatment outcomes.
• Continued research into novel strategies and overcoming challenges is crucial.
• Future perspectives involve integrating diverse immunotherapeutic approaches for better patient survival.